Form 4: Beam Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Bethany J Cavanagh, SVP, Finance and Treasurer of Beam Therapeutics Inc., sold 187 shares of common stock on October 1, 2026 for $24.41 per share.
Summary
- Open-market sale: disposed of 187 Common Stock at $24.41 ($4,565) on October 1, 2026; holds 50,984 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $4,565 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Bethany J Cavanagh — Officer (SVP, Finance and Treasurer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Open-market sale | Common Stock | 187 | $24 | $4.6K | 50,984 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Open-market sale (187 shares) |
Keywords
insider transaction, Form 4, BEAM, Beam Therapeutics Inc., bearish, Bethany J Cavanagh
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.